BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35071007)

  • 21.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
    Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
    Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [
    Wang Y; Zhang Y; Chen Y; Wang S; Liu W; Liu Z; Hu M
    Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38713298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
    Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a
    Fu L; Huang J; Liu Q; Xie F; Han Y; Sun P; Cao M; Huang Y; Hu K; Tang G
    Bioorg Chem; 2023 Dec; 141():106878. PubMed ID: 37774434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated GMP compliant production of [
    Tshibangu T; Cawthorne C; Serdons K; Pauwels E; Gsell W; Bormans G; Deroose CM; Cleeren F
    EJNMMI Radiopharm Chem; 2020 Jan; 5(1):4. PubMed ID: 31997090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.
    Lee IK; Noguera-Ortega E; Xiao Z; Todd L; Scholler J; Song D; Liousia M; Lohith K; Xu K; Edwards KJ; Farwell MD; June CH; Albelda SM; Puré E; Sellmyer MA
    Clin Cancer Res; 2022 Dec; 28(24):5330-5342. PubMed ID: 35972732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated radiosynthesis and preclinical evaluation of Al[
    Huang S; Wu H; Li B; Fu L; Sun P; Wang M; Hu K
    Nucl Med Biol; 2020; 82-83():64-71. PubMed ID: 32088580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor targeting efficacy of a novel PET radiotracer (1)8F-AlF-NOTA-PRGD2 in mice].
    Wu H; Wang Q; Han Y; Zhou W; Li H; Tian Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):51-5. PubMed ID: 24463116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Value of
    Qin X; Wang S; Liu X; Duan J; Cheng K; Mu Z; Jia J; Wei Y; Yuan S
    Front Oncol; 2022; 12():879281. PubMed ID: 35719937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosynthesis and First Preclinical Evaluation of the Novel
    Wang C; Hu Z; Ding F; Zhao H; Du F; Lv C; Li L; Huang G; Liu J
    Front Chem; 2022; 10():939160. PubMed ID: 35991604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hexavalent lactoside labeled with [
    Yu HM; Chan CH; Yang CH; Hsia HT; Wang MH
    Appl Radiat Isot; 2020 Aug; 162():109199. PubMed ID: 32501233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and Evaluation of [
    Xiao D; Gan Q; Duan X; Wang Q; Jiang Y; Han P; Zhang J
    Mol Pharm; 2023 Sep; 20(9):4528-4536. PubMed ID: 37661815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-Clinical Study of the [
    Han J; Chen Y; Zhao Y; Zhao X; Zhang J; Wang J; Zhang Z
    Front Med (Lausanne); 2022; 9():803005. PubMed ID: 35252244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization and scale up of production of the PSMA imaging agent [
    Alexoff D; Choi SR; Ploessl K; Kim D; Zhao R; Zhu L; Kung H
    EJNMMI Radiopharm Chem; 2024 Feb; 9(1):15. PubMed ID: 38393404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Preliminary Evaluation of
    Ma H; Li F; Shen G; Cai H; Liu W; Lan T; Yang Y; Yang J; Liao J; Liu N
    Mol Pharm; 2021 Nov; 18(11):4179-4187. PubMed ID: 34591481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.